live-attenuated Lmdd-gag vaccine (Immune Disease Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namelive-attenuated Lmdd-gag vaccine (Immune Disease Institute)

Drug Alias Namelive-attenuated Listeria monocytogenes-HIV-1 gag vaccine (Immune Disease Institute)

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine +[4]

Mechanisms of ActionCluster of differentiation 8 stimulantsGlycosaminoglycan modulators

TargetsGlycosaminoglycanCluster of differentiation 8

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmune Disease Institute Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmune Disease Institute Inc

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A